vs

Side-by-side financial comparison of MERCANTILE BANK CORP (MBWM) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $67.6M, roughly 1.9× MERCANTILE BANK CORP). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 9.1%).

Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

MBWM vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.9× larger
ZLAB
$127.1M
$67.6M
MBWM
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
9.1%
MBWM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MBWM
MBWM
ZLAB
ZLAB
Revenue
$67.6M
$127.1M
Net Profit
$22.7M
Gross Margin
51.0%
Operating Margin
-54.6%
Net Margin
33.6%
Revenue YoY
17.1%
Net Profit YoY
16.1%
EPS (diluted)
$1.32
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBWM
MBWM
ZLAB
ZLAB
Q1 26
$67.6M
Q4 25
$62.1M
$127.1M
Q3 25
$62.4M
$115.4M
Q2 25
$60.9M
$109.1M
Q1 25
$57.3M
$105.7M
Q4 24
$58.5M
$108.5M
Q3 24
$58.0M
$101.8M
Q2 24
$56.8M
$100.1M
Net Profit
MBWM
MBWM
ZLAB
ZLAB
Q1 26
$22.7M
Q4 25
$22.8M
Q3 25
$23.8M
$-36.0M
Q2 25
$22.6M
$-40.7M
Q1 25
$19.5M
$-48.4M
Q4 24
$19.6M
Q3 24
$19.6M
$-41.7M
Q2 24
$18.8M
$-80.3M
Gross Margin
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Operating Margin
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
42.0%
-54.6%
Q3 25
44.0%
-42.3%
Q2 25
42.6%
-50.3%
Q1 25
42.0%
-53.3%
Q4 24
39.7%
-62.6%
Q3 24
42.4%
-66.6%
Q2 24
41.4%
-76.0%
Net Margin
MBWM
MBWM
ZLAB
ZLAB
Q1 26
33.6%
Q4 25
36.8%
Q3 25
38.1%
-31.2%
Q2 25
37.1%
-37.3%
Q1 25
34.1%
-45.8%
Q4 24
33.5%
Q3 24
33.8%
-40.9%
Q2 24
33.1%
-80.2%
EPS (diluted)
MBWM
MBWM
ZLAB
ZLAB
Q1 26
$1.32
Q4 25
$1.41
$-0.05
Q3 25
$1.46
$-0.03
Q2 25
$1.39
$-0.04
Q1 25
$1.21
$-0.04
Q4 24
$1.20
$-0.09
Q3 24
$1.22
$-0.04
Q2 24
$1.17
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBWM
MBWM
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$689.6M
Total DebtLower is stronger
$1.5M
Stockholders' EquityBook value
$736.9M
$715.5M
Total Assets
$6.9B
$1.2B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
$689.6M
Q3 25
$717.2M
Q2 25
$732.2M
Q1 25
$757.3M
Q4 24
$779.7M
Q3 24
$616.1M
Q2 24
$630.0M
Total Debt
MBWM
MBWM
ZLAB
ZLAB
Q1 26
$1.5M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
MBWM
MBWM
ZLAB
ZLAB
Q1 26
$736.9M
Q4 25
$724.9M
$715.5M
Q3 25
$657.6M
$759.9M
Q2 25
$631.5M
$791.7M
Q1 25
$608.3M
$810.8M
Q4 24
$584.5M
$840.9M
Q3 24
$583.3M
$667.7M
Q2 24
$551.2M
$704.2M
Total Assets
MBWM
MBWM
ZLAB
ZLAB
Q1 26
$6.9B
Q4 25
$6.8B
$1.2B
Q3 25
$6.3B
$1.2B
Q2 25
$6.2B
$1.2B
Q1 25
$6.1B
$1.2B
Q4 24
$6.1B
$1.2B
Q3 24
$5.9B
$985.3M
Q2 24
$5.6B
$987.4M
Debt / Equity
MBWM
MBWM
ZLAB
ZLAB
Q1 26
0.00×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBWM
MBWM
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
$18.0M
$-26.0M
Q3 25
$23.1M
$-32.0M
Q2 25
$-7.8M
$-31.0M
Q1 25
$-3.0M
$-61.7M
Q4 24
$101.1M
$-55.8M
Q3 24
$-8.1M
$-26.8M
Q2 24
$9.1M
$-42.2M
Free Cash Flow
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
FCF Margin
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Capex Intensity
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Cash Conversion
MBWM
MBWM
ZLAB
ZLAB
Q1 26
Q4 25
0.79×
Q3 25
0.97×
Q2 25
-0.35×
Q1 25
-0.15×
Q4 24
5.15×
Q3 24
-0.41×
Q2 24
0.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MBWM
MBWM

Net Interest Income$55.9M83%
Noninterest Income$11.7M17%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons